# Preventive Medicine/Screening: (USPSTF) 

Whitney George

---

-	Refer to US Preventative Services Task Force for complete list of Grade A & B recommendations: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations
-	Grade A recommendation definition: There is high certainty that the net benefit is substantial.
-	Grade B recommendation definition: There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
-	Recommend downloading the “CDC Vaccine Schedules” App on your phone to easily filter by medical condition or look at contraindications

<table>
 <tr><th colspan='3'>Preventative Measures for WOMEN</th></tr>
 <tr>
    <th>Preventative Measure</th>
    <th>Guidelines</th>
    <th>Grade</th>
  </tr>
  <tr>
    <td>Cervical cancer</td>
    <td>Ages 21-29: q 3 yrs with cervical cytology alone.<br>Ages 30-65: q 3 yrs with cervical cytology alone, every 5 years w/ high-risk human papillomavirus (hrHPV) testing alone<br>or q 5 yrs with hrHPV testing in<br>combination with cytology (co-testing)<br>***ACS 2020 guideline change –Age 25-65:  preferred HPV test alone q 5 years (or HPV/Pap co-test every 5 years or a Pap every 3 years)***</td>
    <td>Grade A</td>
  </tr>
  <tr>
    <td>Breast cancer</td>
    <td>Women 50-74:  q2 years<br>ACS recommends beginning at age 45-54 annually, 55+ q2 hrs in women with average risk. <br>If family or personal history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated BRCA1/2 gene mutations - should assess risk and refer to genetic counseling.</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Folic acid</td>
    <td>All women who are planning or capable of pregnancy should take daily folic acid supplement (0.4 – 0.8 mg daily)</td>
    <td>Grade A</td>
  </tr>
  <tr>
    <td>Chlamydia Gonorrhea</td>
    <td>All sexually active women < 24, older women with increased risk</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Osteoporosis (DEXA)</td>
    <td>Women >65, postmenopausal women <65 with increased osteoporosis risk (can use FRAX tool)</td>
    <td>Grade B</td>
  </tr>
</table>

<table>
  <tr><th colspan='3'>Preventative Measures for MEN</th></tr><tr>
    <th>Preventive Measure</th>
    <th>Guidelines</th>
    <th>Grade</th>
  </tr>
  <tr>
    <td>Abdominal aortic aneurysm (AAA) screening</td>
    <td>Men Ages 65-75 who ever smoked (at least 100 cigarettes total): one-time screening by ultrasonography</td>
    <td>Grade B</td>
  </tr>
</table>

<table>
 <tr><th colspan='3'>Preventative Measures for ALL pts</th></tr> <tr>
    <th>Preventative Measure</th>
    <th>Guidelines</th>
    <th>Grade</th>
  </tr>
  <tr>
    <td>Cholesterol screening</td>
    <td>Men &gt;35 or 20-35 with CV risk<br>Women &gt;45 or 20-45 with CV risk</td>
    <td>UpToDate: Grade 2C</td>
  </tr>
  <tr>
    <td>Colorectal cancer</td>
    <td>All adults age 45-75<br>FOBT annually<br>FIT annually<br>FIT-DNA (Cologuard) q1-3 years<br>Colonoscopy q 10 years<br>Flexible sigmoidoscopy q 5 years<br><br>Screen earlier if: family hx of CRC or adenomatous polyps at age &lt; 60, hx of IBD, a confirmed or suspected hereditary CRC syndrome, or a hx abdominal/pelvic radiation</td>
    <td>Grade A for ages 50-75; Grade B for ages 45-49</td>
  </tr>
  <tr>
    <td>Depression</td>
    <td>Screen for depression in general adult populations. If screening, must ensure systems are in place for accurate diagnosis, effective treatment, and appropriate follow up</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Diabetes screening</td>
    <td>Adults age 35-70 who are overweight or obese</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Falls</td>
    <td>Provide exercise interventions to prevent falls in community-dwelling adults &gt;65 years old who are at increased risk for falls</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td rowspan='3'>Cardiovascular health</td>
    <td>Blood pressure screening annually adults &gt;18</td>
    <td>Grade A</td>
  </tr>
  <tr>
    <td>Aspirin 81 mg in age 50-59 with ASCVD risk &gt;10% in 10 years, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Statin: See section on Lipids</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Hepatitis C</td>
    <td>Adults aged 18 to 79 years (one time screening)</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>HIV</td>
    <td>All adolescents and adults 15-65 (one time screening)</td>
    <td>Grade A</td>
  </tr>
  <tr>
    <td>Lung cancer</td>
    <td>Low-dose CT adults 50-80 w/20 pack year smoking history and currently smoke or quit within the past 15 years<br><br>Should discuss risk vs benefits, particularly in pts with serious co-morbidities who may not tolerate/desire surgery or aggressive treatment.</td>
    <td>Grade B</td>
  </tr>
  <tr>
    <td>Obesity</td>
    <td>BMI annually in all adults</td>
    <td>Grade A</td>
  </tr>
</table>
